| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390403A2 Peptides derived from neural thread proteins and their medical use |
| 02/25/2004 | EP1390400A2 Pharmaceutical use for secreted bacterial effector proteins |
| 02/25/2004 | EP1390398A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 02/25/2004 | EP1390393A2 Pentapeptide compounds and uses related thereto |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390385A2 Nucleic acid based modulation of female reproductive diseases and conditions |
| 02/25/2004 | EP1390372A1 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 02/25/2004 | EP1390371A1 Oxazolo-and furopyrimidines and their use in medicaments against tumors |
| 02/25/2004 | EP1390369A1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/25/2004 | EP1390368A1 Disubstituted 7,9-guaninium halides as telomerase inhibitors |
| 02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
| 02/25/2004 | EP1390360A1 Crystalline form of omeprazole |
| 02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
| 02/25/2004 | EP1390352A1 Pyrimidine derivatives |
| 02/25/2004 | EP1390351A1 Pyrimidine derivatives useful as selective cox-2 inhibitors |
| 02/25/2004 | EP1390350A1 Novel compounds |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390348A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors |
| 02/25/2004 | EP1390347A1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 02/25/2004 | EP1390344A2 Organic compounds |
| 02/25/2004 | EP1390080A1 Azo compounds for type i phototherapy |
| 02/25/2004 | EP1390079A2 Paramagnetic metal ion-based macrocylic contrast agents |
| 02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
| 02/25/2004 | EP1390071A2 Symbiotic regenerative agent |
| 02/25/2004 | EP1390070A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 02/25/2004 | EP1390063A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1390054A2 Mu-conopeptides |
| 02/25/2004 | EP1390046A2 Treatment of neoplasms with viruses |
| 02/25/2004 | EP1390045A1 The use of a compound with a negatively charged domain of radicals for the treatment of restenosis |
| 02/25/2004 | EP1390037A1 Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 02/25/2004 | EP1390031A2 Topical composition containing a fungicide |
| 02/25/2004 | EP1390021A1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1389970A2 Compositions and methods of double-targeting virus infections and cancer cells |
| 02/25/2004 | EP1300407B1 Carbamates derived from arylalkylamines |
| 02/25/2004 | EP1292293B1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same |
| 02/25/2004 | EP1283837B1 New thiochromane derivatives and their use as thrombin inhibitors |
| 02/25/2004 | EP1267902B1 Cosmetic use of hop and ornithine |
| 02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 02/25/2004 | EP1239878B1 Formulations of adenosine a1 agonists and 5ht1 agonists |
| 02/25/2004 | EP1230232B1 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 02/25/2004 | EP1230223B1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1210326B1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/25/2004 | EP1200443B1 Aromatic esters of camptothecins and methods to treat cancers |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | EP1178986B1 Furanone derivatives as inhibitors of cathepsin s |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1149067B1 7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents |
| 02/25/2004 | EP1140931B1 5ht1 antagonists for antidepressant therapy |
| 02/25/2004 | EP1117392B1 Method for preventing or delaying catheter-based revascularization |
| 02/25/2004 | EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants |
| 02/25/2004 | EP1039908B1 Molecular dispersion composition with enhanced bioavailability |
| 02/25/2004 | EP1037607B1 Novel suppository form comprising an acid-labile active compound |
| 02/25/2004 | EP0988797B1 Use of compositions for postgastrectomic mineral supply |
| 02/25/2004 | EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 02/25/2004 | EP0948308B1 Methods for treating skin pigmentation |
| 02/25/2004 | EP0883405B1 Amidino protease inhibitors |
| 02/25/2004 | EP0831834B1 Debromohymenialdisine and related compounds for treating osteoarthritis |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0749478B1 Yeast strains and modified albumins |
| 02/25/2004 | EP0688210B1 Use of carnosine in combination with urocanic acid for treatment of photodermatoses |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478145A Differentiated cells suitable for human therapy |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478090A Substituted imidazopyridines |
| 02/25/2004 | CN1478088A Benzothiophene derivative compounds, process of preparation and use thereof |
| 02/25/2004 | CN1478087A Indolylmaleimide derivatives as protein kinase C inibitors |
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
| 02/25/2004 | CN1478081A Substituted 2-znilino-benzimidazoles and use thereof as NHE-inhibitors |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478077A Benzamide compounds as APOB secretion inhibitors |
| 02/25/2004 | CN1478072A Tetralone derivatives as antitumor agents |
| 02/25/2004 | CN1477976A Combination of GABA agonists and aldose reductase inhibitors |
| 02/25/2004 | CN1477968A Methods for treating rheumatic diseases using soluble CTLA4 molecule |
| 02/25/2004 | CN1477967A Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 02/25/2004 | CN1477964A Treatment of neoplasms with viruses |
| 02/25/2004 | CN1477961A Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1477957A Tanshinone compound containing dihydrofuran ring structure for curing hyperammonemia and hepatic encephalopathy |
| 02/25/2004 | CN1477956A Crytotanshinone for preventing and delaying early senile dementia |
| 02/25/2004 | CN1477126A Long-acting growth hormone and medicine composition |
| 02/25/2004 | CN1476885A Nianmoyankuiling for curing mucositis mucitis and its preparation |
| 02/25/2004 | CN1476833A Preparation method of medicine for curing urteriosclerosis by using CS-866, losartan and candisartan |
| 02/25/2004 | CN1139656C Quick high-effective separation and purification method of virus related to recombinant adenovirus and its application |
| 02/25/2004 | CN1139595C Crystalline macrolides and its preparation method |
| 02/25/2004 | CN1139588C Novel fluorinated imidazoline benzodioxane, preparation and therapeutic use thereof |
| 02/25/2004 | CN1139584C Heterocyclic compounds, method for preparing and medicine composition containing same |
| 02/25/2004 | CN1139579C Isoxazolecarboxamide derivatives |
| 02/25/2004 | CN1139570C Inhibition of matrix metalloproteases by acetylene-containing compound |
| 02/25/2004 | CN1139384C Therapeutic composition based on flavonoids for use in treatment of tumours with cytotoxic agents |
| 02/25/2004 | CN1139383C Therapeutic composition containing isoflavonoids for process in treatment of tumours with cytotoxic agents |
| 02/24/2004 | US6696567 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/24/2004 | US6696555 3'-Desoxypentopyranosyl nucleic acid, its production and its use |
| 02/24/2004 | US6696498 2-cyclopenten-1-one and its derivatives as inhibitors of the NF-kB factor |